Houlihan Lokey Advises T-Pro

Houlihan Lokey is pleased to announce that T-Pro, a global leader in clinical document workflow software, has received a minority investment from Livingbridge, one of the UK’s leading middle-market private equity investors.

Founded in 2012 and headquartered in Dublin, T-Pro’s best-in-class, AI-powered speech technology enables more efficient and accurate document workflows across a full spectrum of healthcare settings. This allows healthcare providers to voice-enable their existing electronic patient record, reduce traditional transcription costs, improve clerical efficiency, and capture patient information effectively and efficiently from anywhere on any device.

T-Pro has grown rapidly in recent years via the launch of new software products and the expansion of its customer base in Ireland, the UK, Australia, and New Zealand, acquiring Syberscribe in Melbourne in 2022. Livingbridge’s investment will enable T-Pro to continue developing its market-leading dictation and speech products, further advance its AI capabilities, and support international expansion and acquisitions.

Livingbridge has been a long-standing investor across the healthcare and software sectors internationally for more than 25 years and will support T-Pro via its global team based in London, Manchester, Melbourne, and Boston.

Houlihan Lokey both originated and acted as the lead advisor on the transaction, providing corporate finance advice to T-Pro. This transaction highlights Houlihan Lokey's focus and expertise in the healthcare software and the public sector software spaces.

RELATED: Healthcare and Pharma